Novel pulmonary hypertension drug proves safe and effective in Phase III Trial
After a year of being treated with a novel drug, patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) and those with persistent or recurrent pulmonary hypertension after an operation for the disease ...
May 19, 2014
0
0